Boothbay Fund Management, LLC Selecta Biosciences Inc Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $17,945 - $37,499	26,785 New	26,785 $35,000
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $14,783 - $39,782	-12,019 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.43 $34,734 - $53,244	12,019 New	12,019 $39,000
Q1 2020 May 15, 2020	SELL	$1.5 - $4.52 $248,737 - $749,528	-165,825 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.32 - $2.47 $218,889 - $409,587	165,825 New	165,825 $395,000
Q2 2018 Aug 14, 2018	SELL	$9.36 - $13.25 $285,498 - $404,151	-30,502 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$8.49 - $11.82 $258,961 - $360,533	30,502 New	30,502 $311,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.